Cite
HARVARD Citation
Berberich, A. et al. (n.d.). P11.07 LAPTM5 functions as a tumor suppressor via CD40 - NFêB pathway inhibition and represents a potential biomarker for temozolomide sensitivity in CD40 proficient glioblastoma. Neuro-oncology. p. iii43. [Online].